glp 1 drug market GLP-1 Drugs Size to Hit USD 132.79 Bn by 2035 New Demand in an Old
Description
5 In terms of safety, population-based data indicate a favorable neuropsychiatric profile for GLP-1R agonists, with a lower risk of suicidal ideation among adolescents using these drugs compared to controls
Primary site of GLP-1 secretion are L-cells in small intestine and colon, but it is also secreted by the pancreatic cells and neurons in nucleus tractus solitarus in the brainstem
Diabetes Care 2021;44:290-6.ArticlePubMed 94
This product was approved for the treatment of T2DM
10.17235/reed.2018.5912/2018 70 RoshanovP
